Suchergebnisse - "Zhang, Yongchang"

PubPharm (179)

1

Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Vella, V. | Ditsiou, A. | Chalari, A. | +14

2

First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer

enthalten in: Med (New York, N.Y.) | 2024

von Zeng, L. | Song, L. | Liu, L. | +18

3

Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT : A case report

enthalten in: Thoracic cancer | 2024

von Zhang, X. | Xu, Q. | Zhang, Y.

4

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor : results from three cancer centers in China

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Yan, H. | Song, L. | Li, Y. | +23

5

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China

enthalten in: Cancer immunology immunotherapy | 2024

von Yan, H. | Song, L. | Li, Y. | +23

6

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors

enthalten in: Global medical genetics | 2024

von Xu, C. | Wang, Q. | Wang, D. | +98

7

EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation

enthalten in: The Journal of experimental medicine | 2024

von Qin, Z. | Yue, M. | Tang, S. | +30

8

Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT : A case report

enthalten in: Thoracic Cancer | 2024

von Zhang, X. | Xu, Q. | Zhang, Y.

9

Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China

enthalten in: Thoracic cancer | 2023

von Pu, X. | Xu, C. | Wang, Q. | +98

10

Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb : A case report

enthalten in: Heliyon | 2023

von Xiang, S. | Zeng, L. | Xiang, M. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]